The Contribution of Genetically Determined Oxidation Status to Inter-individual Variation in Phenacetin Disposition

Overview

Journal Br J Clin Pharmacol

Specialty Pharmacology

Date 1983 Aug 1

PMID 6615690

Citations 8

Authors

H W Devonshire

I Kong

M Cooper

T P Sloan

J R Idle

R L Smith

Affiliations

Soon will be listed here.

Abstract

The oxidative O-de-ethylation and aromatic 2-hydroxylation of phenacetin have been investigated in panels of extensive (EM, n = 13) and poor (PM, n = 10) metabolizers of debrisoquine. The EM group excreted in the urine significantly more paracetamol (EM: 40.8 +/- 14.9% dose/0-8 h; PM: 29.2 +/- 8.7% dose/0-8 h, 2P less than 0.05) and significantly less 2-hydroxylated metabolites (EM: 4.7 +/- 2.3% dose/0-8 h; PM: 9.7 +/- 3.5% dose/0-8 h, 2P less than 0.005) than the PM group. Apparent first-order rate constants, calculated from pooled phenotype data, for overall elimination of phenacetin (k) and formation of paracetamol (kml) were higher in the EM group (EM: k = 0.191 +/- 0.151 h-1; kml = 0.091 +/- 0.025 h-1; PM: k = 0.098 +/- 0.035 h-1, 2P less than 0.05, kml = 0.052 +/- 0.019 h-1, 2P less than 0.05) than the PM group. The apparent first-order rate constant for 2-hydroxylation displayed no significant inter-phenotype differences. Correlation analysis demonstrated that genetically determined oxidation status accounted for approximately 50% of the inter-individual variability in phenacetin disposition encountered in this study.

Citing Articles

Genetics of caffeine consumption and responses to caffeine.

Yang A, Palmer A, de Wit H Psychopharmacology (Berl). 2010; 211(3):245-57.

PMID: 20532872 PMC: 4242593. DOI: 10.1007/s00213-010-1900-1.

The genetic control of phenformin 4-hydroxylation.

Shah R, Evans D, Oates N, Idle J, Smith R J Med Genet. 1985; 22(5):361-6.

PMID: 4078865 PMC: 1049479. DOI: 10.1136/jmg.22.5.361.

The relationship between the acetylator and the sparteine hydroxylation polymorphisms.

Harmer D, Evans D, Eze L, Jolly M, Whibley E J Med Genet. 1986; 23(2):155-6.

PMID: 3712391 PMC: 1049571. DOI: 10.1136/jmg.23.2.155.

Poor sulphoxidation ability in patients with food sensitivity.

Scadding G, Ayesh R, Brostoff J, Mitchell S, Waring R, Smith R BMJ. 1988; 297(6641):105-7.

PMID: 3408928 PMC: 1833819. DOI: 10.1136/bmj.297.6641.105.

Metabolic basis of adverse drug reactions.

Park B J R Coll Physicians Lond. 1986; 20(3):195-200.

PMID: 2874223 PMC: 5371054.

References

Murray R . Genesis of analgesic nephropathy in the United Kingdom. Kidney Int. 1978; 13(1):50-7. DOI: 10.1038/ki.1978.7. View

Sloan T, Mahgoub A, Lancaster R, Idle J, Smith R . Polymorphism of carbon oxidation of drugs and clinical implications. Br Med J. 1978; 2(6138):655-7. PMC: 1607381. DOI: 10.1136/bmj.2.6138.655. View

Bertilsson L, DENGLER H, Eichelbaum M, Schulz H . Pharmacogenetic covariation of defective N-oxidation of sparteine and 4-hydroxylation of debrisoquine. Eur J Clin Pharmacol. 1980; 17(2):153-5. DOI: 10.1007/BF00562624. View

Shah R, Oates N, Idle J, Smith R . Genetic impairment of phenformin metabolism. Lancet. 1980; 1(8178):1147. DOI: 10.1016/s0140-6736(80)91604-9. View

Evans D, Mahgoub A, Sloan T, Idle J, Smith R . A family and population study of the genetic polymorphism of debrisoquine oxidation in a white British population. J Med Genet. 1980; 17(2):102-5. PMC: 1048511. DOI: 10.1136/jmg.17.2.102. View

Sloan T, Idle J, Smith R . Influence of DH/DL alleles regulating debrisoquine oxidation on phenytoin hydroxylation. Clin Pharmacol Ther. 1981; 29(4):493-7. DOI: 10.1038/clpt.1981.68. View

Davies D, Kahn G, Murray S, Brodie M, Boobis A . Evidence for an enzymatic defect in the 4-hydroxylation of debrisoquine by human liver. Br J Clin Pharmacol. 1981; 11(1):89-91. PMC: 1401705. DOI: 10.1111/j.1365-2125.1981.tb01108.x. View

Poli M . [Familial chronic bilateral kidney disease]. Helv Med Acta. 1955; 22(2):109-22. View

Ask-Upmark E . Migraine as a deadly disease. Br Med J. 1960; 2(5202):823-5. PMC: 2097781. DOI: 10.1136/bmj.2.5202.823. View

10.

Cummings A, Martin B, Park G . Kinetic considerations relating to the accrual and elimination of drug metabolites. Br J Pharmacol Chemother. 1967; 29(2):136-49. PMC: 1557201. DOI: 10.1111/j.1476-5381.1967.tb01947.x. View

11.

Cummings A, King M, Martin B . A kinetic study of drug elimination: the excretion of paracetamol and its metabolites in man. Br J Pharmacol Chemother. 1967; 29(2):150-7. PMC: 1557197. DOI: 10.1111/j.1476-5381.1967.tb01948.x. View

12.

Martin B . Drug urinary excretion data--some aspects concerning the interpretation. Br J Pharmacol Chemother. 1967; 29(2):181-93. PMC: 1557205. DOI: 10.1111/j.1476-5381.1967.tb01951.x. View

13.

Buch H, Gerhards W, Karachristianidis G, Pfleger K, RUMMEL W . [Inhibition of the phenacetin and p-phenetidin induced methemoglobin picture by barbiturates]. Biochem Pharmacol. 1967; 16(8):1575-83. DOI: 10.1016/0006-2952(67)90136-0. View

14.

B4uch H, Gerhards W, Pfleger K, Rudiger W, RUMMEL W . [Metabolic transformation of phenacetin and N-acetyl-p-aminophenol after pretreatment with phenobarbital]. Biochem Pharmacol. 1967; 16(8):1585-99. DOI: 10.1016/0006-2952(67)90137-2. View

15.

SHAHIDI N, Hemaidan A . Acetophenetidin-induced methemoglobinemia and its relation to the excretion of diazotizable amines. J Lab Clin Med. 1969; 74(4):581-5. View

16.

RAAFLAUB J, Dubach U . Dose-dependent change in the pattern of phenacetin metabolism in man and its possible significance in analgesic nephropathy. Klin Wochenschr. 1969; 47(23):1286-7. DOI: 10.1007/BF01487561. View

17.

Nery R . Some new aspects of the metabolism of phenacetin in the rat. Biochem J. 1971; 122(3):317-26. PMC: 1176781. DOI: 10.1042/bj1220317. View

18.

Thomas B, COLDWELL B, Zeitz W, Solomonraj G . Effect of aspirin, caffeine, and codeine on the metabolism of phenacetin and acetaminophen. Clin Pharmacol Ther. 1972; 13(6):906-10. DOI: 10.1002/cpt1972136906. View

19.

NORDENFELT O . Deaths from renal failure in abusers of phenacetin-containing drugs. Acta Med Scand. 1972; 191(1-2):11-6. View

20.

JAFFE E . Oxidative hemolysis, or "what made the red cell break"?. N Engl J Med. 1972; 286(3):156-7. DOI: 10.1056/NEJM197201202860311. View